← Back to Clinical Trials
Recruiting NCT07279571

NCT07279571 GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07279571
Status Recruiting
Phase —
Sponsor University of Southern California
Condition Gynecologic Disease
Study Type OBSERVATIONAL
Enrollment 48 participants
Start Date 2026-06-12
Primary Completion 2027-06-09

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Non-Interventional Study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 48 participants in total. It began in 2026-06-12 with a primary completion date of 2027-06-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study seeks to understand how endometrial cancer patients get medical information about cancer care and their satisfaction with those health-seeking methods. It also assesses patient interest in using an artificial intelligence educational resource.

Eligibility Criteria

AI-chatbot Evaluation (Aim 1): Inclusion Criteria: * Patient of the LA General gynecologic oncology clinic * Age 18 years or older * Previously obtained the HPV vaccination (initial chatbot evaluation) * Eligible for HPV vaccination (pilot intervention; age \<46) * Willing and able to provide informed consent Exclusion Criteria: * Patients who do not speak English or Spanish * Patients who do not provide informed consent HPV vaccination rate (Aim 2): Inclusion Criteria: * Patient of the LA General gynecologic oncology clinic * Age 18 years or older * Obtained the HPV vaccine Exclusion Criteria: * None

Contact & Investigator

Principal Investigator

Xiaoyue M Guo

PRINCIPAL INVESTIGATOR

University of Southern California

Frequently Asked Questions

Who can join the NCT07279571 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Gynecologic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07279571 currently recruiting?

Yes, NCT07279571 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Southern California to inquire about joining.

Where is the NCT07279571 trial being conducted?

This trial is being conducted at Los Angeles, United States.

Who is sponsoring the NCT07279571 clinical trial?

NCT07279571 is sponsored by University of Southern California. The principal investigator is Xiaoyue M Guo at University of Southern California. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology